Cargando…

598. Choosing Wisely with CD4 Counts: When Less Is More

BACKGROUND: The HIVMA and Choosing Wisely campaign recommend using a simple lymphocyte panel for monitoring CD4 counts of patients with HIV. This panel shows CD4 absolute and percentage counts only. Complex lymphocyte panels, which are more comprehensive and expensive, often do not offer more clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Don Bambino Geno, Yu, Arlene, Goldstein, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253300/
http://dx.doi.org/10.1093/ofid/ofy210.605
_version_ 1783373466477527040
author Tai, Don Bambino Geno
Yu, Arlene
Goldstein, Robert
author_facet Tai, Don Bambino Geno
Yu, Arlene
Goldstein, Robert
author_sort Tai, Don Bambino Geno
collection PubMed
description BACKGROUND: The HIVMA and Choosing Wisely campaign recommend using a simple lymphocyte panel for monitoring CD4 counts of patients with HIV. This panel shows CD4 absolute and percentage counts only. Complex lymphocyte panels, which are more comprehensive and expensive, often do not offer more clinically valuable information. Increasing the rate of simple panel utilization can significantly save costs for the healthcare system without compromising care. METHODS: A before-and-after study was conducted in two community-based teaching hospitals with total capacity of 418 inpatient beds, and an outpatient HIV/AIDS center. All panels ordered from March 2016 to March 2018 were included in the study. Intervention started in November 2017. Simple panel was shown as the default test when CD4 test was ordered in the electronic health record while complex panels were eventually phased out. Panels ordered before and after the intervention were counted, and proportions compared. Costs were computed based on 2017 Medicare reimbursement rates. RESULTS: A total of 1,701 panels were done in the study period. 1,401 were ordered pre-intervention (20 months) while 300 were post-intervention (5 months). Complex panels represented 99% (n = 1,398) of tests ordered pre-intervention. The average cost of each test was $167.67. The healthcare system lost ~$183,051 due to added expense of complex panels during this period. In the post-intervention period, proportion of complex panels fell by 85% (95% CI 80.57–88.5, P < 0.0001). Average cost per test post-intervention lowered to $55.54. The mean difference was $112.13 and was statistically significant (95% CI 107.78–116.47; P < 0.0001). The percentage of simple panels consistently increased month-per-month post-intervention. In the last month of the study period, 100% of orders were simple panels (Figure 1). [Image: see text] CONCLUSION: Use of complex panels for monitoring CD4 count caused unnecessary expenses and resulted in significant losses for the healthcare system. An efficient and effective intervention to increase the use of simple panels was to implement an opt-out policy. Simple panels were set as the default test unless the provider specified otherwise. The intervention is projected to save ~$98,761 in 2018. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253300
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62533002018-11-28 598. Choosing Wisely with CD4 Counts: When Less Is More Tai, Don Bambino Geno Yu, Arlene Goldstein, Robert Open Forum Infect Dis Abstracts BACKGROUND: The HIVMA and Choosing Wisely campaign recommend using a simple lymphocyte panel for monitoring CD4 counts of patients with HIV. This panel shows CD4 absolute and percentage counts only. Complex lymphocyte panels, which are more comprehensive and expensive, often do not offer more clinically valuable information. Increasing the rate of simple panel utilization can significantly save costs for the healthcare system without compromising care. METHODS: A before-and-after study was conducted in two community-based teaching hospitals with total capacity of 418 inpatient beds, and an outpatient HIV/AIDS center. All panels ordered from March 2016 to March 2018 were included in the study. Intervention started in November 2017. Simple panel was shown as the default test when CD4 test was ordered in the electronic health record while complex panels were eventually phased out. Panels ordered before and after the intervention were counted, and proportions compared. Costs were computed based on 2017 Medicare reimbursement rates. RESULTS: A total of 1,701 panels were done in the study period. 1,401 were ordered pre-intervention (20 months) while 300 were post-intervention (5 months). Complex panels represented 99% (n = 1,398) of tests ordered pre-intervention. The average cost of each test was $167.67. The healthcare system lost ~$183,051 due to added expense of complex panels during this period. In the post-intervention period, proportion of complex panels fell by 85% (95% CI 80.57–88.5, P < 0.0001). Average cost per test post-intervention lowered to $55.54. The mean difference was $112.13 and was statistically significant (95% CI 107.78–116.47; P < 0.0001). The percentage of simple panels consistently increased month-per-month post-intervention. In the last month of the study period, 100% of orders were simple panels (Figure 1). [Image: see text] CONCLUSION: Use of complex panels for monitoring CD4 count caused unnecessary expenses and resulted in significant losses for the healthcare system. An efficient and effective intervention to increase the use of simple panels was to implement an opt-out policy. Simple panels were set as the default test unless the provider specified otherwise. The intervention is projected to save ~$98,761 in 2018. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253300/ http://dx.doi.org/10.1093/ofid/ofy210.605 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Tai, Don Bambino Geno
Yu, Arlene
Goldstein, Robert
598. Choosing Wisely with CD4 Counts: When Less Is More
title 598. Choosing Wisely with CD4 Counts: When Less Is More
title_full 598. Choosing Wisely with CD4 Counts: When Less Is More
title_fullStr 598. Choosing Wisely with CD4 Counts: When Less Is More
title_full_unstemmed 598. Choosing Wisely with CD4 Counts: When Less Is More
title_short 598. Choosing Wisely with CD4 Counts: When Less Is More
title_sort 598. choosing wisely with cd4 counts: when less is more
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253300/
http://dx.doi.org/10.1093/ofid/ofy210.605
work_keys_str_mv AT taidonbambinogeno 598choosingwiselywithcd4countswhenlessismore
AT yuarlene 598choosingwiselywithcd4countswhenlessismore
AT goldsteinrobert 598choosingwiselywithcd4countswhenlessismore